Skip to content
POM-V Prescription Required

Poulvac Procerta HVT-IBD Concentrate and Solvent for Suspension for Injection for Chickens

Active ingredient: Cell-associated live recombinant turkey herpesvirus

Form

Injection

Species

Chicken embryonated eggs Chickens

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5124

What it's used for

Onset of immunity: MD: 7 days post vaccination for in ovo and 9 days for subcutaneous use IBD: 15 days post vaccination for in ovo and 14 days for subcutan...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Cell-associated live recombi...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Poulvac Procerta HVT-IBD Concentrate and Solvent for Suspension for Injection for Chickens — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: MD: 7 days post vaccination for in ovo and 9 days for
subcutaneous use
IBD: 15 days post vaccination for in ovo and 14 days for
subcutaneous use
Duration of immunity: MD: a single vaccination is sufficient to provide protection
for the entire risk period
IBD: 64 days of age
One single injection of 0.2 ml per chicken at day of hatch, by subcutaneous use.
One single injection of 0.05 ml per chicken egg at 18-19 days of embryonation, by in
ovo route.
Preparation of the vaccine:
Preparation of the vaccine shall be planned before the ampoules are taken from the
liquid nitrogen and the exact amount of vaccine ampoules and amount of solvent
needed shall be calculated first. There is no information available on the number of
doses on the ampoules once they are removed from the cane. Special care has to
be taken to ensure that mix-ups of ampoules with different number of doses is
avoided and the correct volume of solvent (Poulvac Solvent) is used.
For subcutaneous use, reconstitute each 2,000 doses with 400 ml of Poulvac
Solvent and each 4,000 doses with 800 ml of Poulvac Solvent. For in ovo use,
reconstitute each 2,000 doses with 100 ml of Poulvac Solvent and 4,000 doses with
200 ml of Poulvac Solvent. The solvent must be at room temperature (15 °C – 25 °C)
at the time of mixing with the vaccine.
Overview tables for the dilution examples for the different dose presentations for
both subcutaneous and in ovo administration are provided:
Poulvac Solvent bag Number of vaccine ampoules for
subcutaneous use
Bag of 400 ml solvent 1 ampoule containing 2,000 doses Bag of 800 ml solvent 2 ampoules containing 2,000 doses Bag of 800 ml solvent 1 ampoule containing 4,000 doses Poulvac Solvent bag Number of vaccine ampoules for in ovo use Bag of 200 ml solvent2 ampoules containing 2,000 dosesBag of 400 ml solvent 4 ampoules containing 2,000 doses Bag of 400 ml solvent2 ampoules containing 4,000 doses Bag of 800 ml solvent 4 ampoules containing 4,000 doses Bag of 1,000 ml solvent5 ampoules containing 4,000 doses
Reconstitution should be done under aseptic conditions. Before withdrawing the
ampoules from the liquid nitrogen container, protect the hands with gloves, wear long
sleeves and use a face shield or goggles.
It is recommended to handle a maximum of 5 ampoules at a time. After removing the
ampoule(s), the remaining ampoules should be put back immediately into the
canister in the liquid nitrogen container.
Take the ampoule(s) of vaccine out of the liquid nitrogen container and thaw the
vaccine by immersing in water at 25 ºC – 30 ºC, while gently swirling the ampoule(s)
to disperse the content. As soon as vaccine in the ampoule is completely thawed,
remove from the water, dry the ampoule and break the ampoules at its neck.
Once opened, slowly withdraw the total contents of the ampoule carefully into a
10 ml sterile disposable syringe with an 18-gauge needle. Slowly draw about 8 ml of
Poulvac Solvent into the syringe. Turn the syringe 5-10 times to mix the contents
well. Slowly transfer a small volume of the mixture into the empty vaccine ampoule in
order to rinse the ampoule and withdraw this small amount back into the syringe.
Carefully transfer the entire content of the syringe into the Poulvac Solvent container.
Remove the syringe and invert the solvent bag about 10 times to mix the vaccine.
The vaccine is now ready for use.
The ready to use vaccine is a red, slightly opalescent liquid.
In case automated equipment is used for in ovo or subcutaneous administration, the
equipment should be calibrated to ensure that the correct dose is applied to each
egg or chicken. The instructions for use of this device should be followed.
The bag of vaccine should be gently swirled frequently during vaccination to
guarantee that the vaccine suspension remains homogenous and that the correct
vaccine virus titre is administered.
None.
Chickens and embryonated chicken eggs:
None known.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
The vaccine strain may be excreted by vaccinated chickens for a maximum of 6
weeks post-vaccination and has the potential to spread to turkeys and to a very
limited extent to chickens. Safety trials (including reversion to virulence studies in
chickens) have shown that the strain is safe for turkeys and chickens. However,
precautionary measures including following general hygiene principles and taking
particular care in handling animal waste and bedding materials from recently
vaccinated chickens should be taken to avoid spreading of the vaccine strain.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Liquid nitrogen can cause serious freeze burns and thawing ampoules may
occasionally explode as result of sudden temperature changes.
Therefore, liquid nitrogen containers and vaccine ampoules should be handled by
properly trained personnel only.
Personal protective equipment consisting of gloves, facial protection or safety
goggles and skin-covering clothing should be worn when handling the veterinary
medicinal product starting when withdrawing from liquid nitrogen.
Store and use liquid nitrogen only in a dry and well-ventilated place.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Not applicable.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.
Concentrate:
Store and transport frozen in liquid nitrogen (or vapour phase) at or below -150 °C.
Poulvac Solvent:
Store at or below 25 °C. Protect from light.
Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.